MP1, a novel marinopyrroles/pyrrolomycins derivative, has been shown to have activity in a resistant NB cell line overexpressing MYCN by inhibiting MYCN and MCL-1, while stimulating autophagy and inhibition of oxidative phosphorylation (OXPHOS) metabolism [7]. This evidence concerns the gene MYCN and neuroblastoma.